Skip to content
Research use onlyComplimentary shipping on orders over $200 U.S. fulfillment
Reproductive & Hormonal

PT-141

$45Per vial

A cyclic melanocortin receptor agonist derived from Melanotan II, studied in research on central nervous system signaling pathways related to sexual function. Unlike PDE5-targeting compounds, it acts through MC3R/MC4R receptor activation in the hypothalamus.

Vial size1 option

Backordered · Ships as soon as restocked

1
Complimentary shipping over $200 U.S.-based fulfillment
Ships as soon as this size is restocked
Record pending for this size

A certificate for this size has not been published yet. Documentation is added as it is received.

For laboratory research only. Not for human or veterinary use.

About PT-141

PT-141 Overview

PT-141, also known as bremelanotide, is a cyclic peptide analogue derived from melanocortin-related peptide research. In laboratory settings, it is studied for its activity within the melanocortin receptor system and for how this receptor signaling influences broader neuroendocrine pathway biology.

Mechanism of Action & Applications

PT-141 is studied for agonist activity at melanocortin receptors, especially MC3R and MC4R. In research models, this makes it useful for examining melanocortin receptor pharmacology, central signaling pathways, peptide-receptor interactions, and broader neuroendocrine signaling dynamics.

Research History

PT-141 emerged from earlier melanocortin peptide research and is commonly described as a metabolite or derivative related to Melanotan II. Over time, it became a distinct research compound within the melanocortin field, with later development and characterization under the name bremelanotide.

Chemical Information

CAS Number
189691-06-3
Molecular Formula
C50H68N14O10
Molecular Weight
1,025.2 g/mol
PubChem ID
9941379

Researcher Reviews